Galapagos sees cystic fibrosis clinical trials in 2014

BRUSSELS Thu Oct 17, 2013 1:45am EDT

BRUSSELS Oct 17 (Reuters) - Belgian biotech company Galapagos said on Thursday that it was set to start clinical trials on a possible treatment for cystic fibrosis at the end of 2014.

The company said in a statement that it had developed a series of potentiators following laboratory tests and would be presenting its results at the North America Cystic Fibrosis Conference in Utah on Oct 17-19.

Galapagos said it would nominate a pre-clinical candidate by the end of this year, with first clinical trials set to start at the end of 2014.

Galapagos signed a cooperation deal last month worth up to $405 million with U.S. company AbbVie to develop a new treatment for cystic fibrosis.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.